National Health Investors Receivables

National Health Investors posts a receivables of $300M as of March 2026. That compares with $350M in the prior-year period — down 13.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, National Health Investors's receivables was $350M. The latest reading is $300M — a 13.9% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of National Health Investors's financial statement story. At $300M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NHI's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; National Health Investors's other metric pages and overview cover the third.

Judging National Health Investors against Finance peers is usually better than using a market-wide rule of thumb. Business models inside Finance are more comparable, which makes gaps in receivables easier to interpret. Start with $300M here, then scan peer and history charts to see if the gap is persistent.